Phibro Animal Health | PAHC - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
Align Technology USD 363.97M 7.48M 2025-12
ANI Pharmaceuticals USD 122.88M 6.86M 2025-12
Assertio Holdings USD 8.89M 2.29M 2024-06
Aurora Cannabis CAD 88.61M 30.53M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Canopy Growth CAD 53.08M 8.3M 2025-12
Corcept Therapeutics USD 2.54M 2.05M 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Henry Schein USD 2.44B 62M 2025-12
Idexx Laboratories USD 432.46M 10.58M 2025-12
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Merck USD 3.32B 531M 2025-12
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Pacira USD 54.62M 6.02M 2025-12
Phibro Animal Health USD 240.42M 2.58M 2025-12
Prestige Brands USD 131.22M 3.52M 2025-12
Supernus Pharmaceuticals USD 47.53M 4.24M 2025-12
Zoetis USD 743M 60M 2025-12